鶹ý

Feature Channels: Pharmaceuticals

Filters close
Released: 21-Nov-2024 9:20 AM EST
FDA Approves Kedrion's Bolognana Facility for Production of First and Only Treatment for PLGD-1, Ryplazim®
Kedrion Biopharma

Kedrion Biopharma Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the company's manufacturing facility in Bolognana, Italy, to produce RYPLAZIM®.

鶹ý: Wistar Institute and Cameroon Researchers Reveals HIV Latency Reversing Properties in African Plant
Released: 19-Nov-2024 1:55 PM EST
Wistar Institute and Cameroon Researchers Reveals HIV Latency Reversing Properties in African Plant
Wistar Institute

A collaboration between The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential in Croton oligandrus Pierre & Hutch, a species of African tree that has been used in traditional healing in Cameroon to treat a variety of diseases and conditions including cancers and diabetes.

   
Released: 18-Nov-2024 8:35 AM EST
PharmassêtX Files Patent Application on New Form of Drug Substance from Green Tea
PharmassêtX Inc.

PharmassêtX Inc., a late-preclinical stage pharmaceutical development company, today announced that the US Patent and Trademark Office has acknowledged receipt of the Company's patent application entitled "CRYSTALLINE FORM OF EPIGALLOCATECHIN-3-GALLATE." PharmassêtX is developing the novel form of epigallocatechin gallate (EGCG) as a prescription drug for the treatment of inflammatory bowel disease (IBD).

鶹ý: The Wistar Institute’s Education and Training Center Receives $100,000 NIIMBL eXperience Grant
Released: 14-Nov-2024 2:40 PM EST
The Wistar Institute’s Education and Training Center Receives $100,000 NIIMBL eXperience Grant
Wistar Institute

The Wistar Institute’s Hubert J.P. Schoemaker Education and Training Center was the recipient of a $100,000 eXperience grant from NIIMBL to support an immersive weeklong training program at the Institute.

鶹ý: Forensic Science Research Responds to DEA Need for Faster, Better Identification of Drugs Like Fentanyl
Released: 14-Nov-2024 11:00 AM EST
Forensic Science Research Responds to DEA Need for Faster, Better Identification of Drugs Like Fentanyl
West Virginia University

Relief is coming for crime scene investigators and toxicologists who have struggled to accurately and swiftly identify drugs that have been seized by law enforcement and may be relied on as evidence at trial, thanks to a research partnership between West Virginia University and the U.S. Drug Enforcement Administration.

鶹ý: Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers
Released: 14-Nov-2024 10:00 AM EST
Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers
Johns Hopkins Medicine

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and Oregon Health & Science University.

鶹ý: Tufts Mathematics Professor’s Gift Renames Science and Engineering Complex
Released: 13-Nov-2024 2:55 PM EST
Tufts Mathematics Professor’s Gift Renames Science and Engineering Complex
Tufts University

Today, Tufts University announced that Loring Tu, a professor in the Department of Mathematics, has made a substantial gift to name the Science and Engineering Complex (SEC) in honor of his late grandfather, Tsungming Tu, who was a world-renowned doctor and expert on pharmacology, toxicology, and medical education. Going forward, the SEC will be known as the Tsungming Tu Complex (TTC).

     
Released: 13-Nov-2024 12:00 PM EST
Expert Available: The FDA Proposes the Removal of Decongestants Found in Common Cold Medicines
George Washington University

The Federal Drug Administration is looking to remove the oral phenylephrine ingredient from over-the-counter medicines. ...

鶹ý: 33 Binghamton University Researchers Among World’s Top 2%
Released: 12-Nov-2024 3:25 PM EST
33 Binghamton University Researchers Among World’s Top 2%
Binghamton University, State University of New York

Nearly three dozen Binghamton University, State University of New York researchers have been honored for their work by a Stanford University study that looks at the impact of scientists worldwide. The recently released ranking has identified 33 current faculty who were among the top 2% of all researchers in the world in their fields in 2023.

Released: 12-Nov-2024 12:45 PM EST
The Solution to Death From a Fentanyl Overdose Could Lie in Its Chemical Structure
Michigan Medicine - University of Michigan

Scientists have identified a molecule that appears to restore normal breathing in mice following a large dose of fentanyl.

Released: 12-Nov-2024 9:00 AM EST
Montefiore Einstein’s Marina Konopleva Joins Break Through Cancer TeamLab in Fight Against Acute Myelogenous Leukemia
Montefiore Einstein Comprehensive Cancer Center

Marina Konopleva, M.D., Ph.D., director of the Leukemia Program and co-director of the Blood Cancer Institute at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), has joined forces with Break Through Cancer, a collaborative medical research foundation that supports teams of scientists as they advance treatments for some of the world’s deadliest cancers. Dr. Konopleva will play a pivotal role in the Eradicating Minimal Residual Disease (MRD) in Acute Myelogenous Leukemia (AML) TeamLab.

Released: 8-Nov-2024 9:30 AM EST
Inscripta® Announces Biomanufacturing of a Rapidly Growing Anti-Aging Skincare Ingredient
Inscripta

Inscripta, Inc., a leading life science technology company helping to create the bioeconomy, has successfully completed scale-up runs and is moving into commercial manufacturing of an anti-aging skincare ingredient.

鶹ý: Selenium Raised Pharmaceutical Value of Garden Sage
Released: 5-Nov-2024 3:45 AM EST
Selenium Raised Pharmaceutical Value of Garden Sage
Scientific Project Lomonosov

Scientists from Immanuel Kant Baltic Federal University showed that spraying of selenium stimulates the growth of garden sage – a plant, that is used in medicine for treatment of inflammations and diseases of gastrointestinal tract.

   
鶹ý: A New Study Highlights Microalgae as Sustainable Ingredients for Food and Pharmaceutical Applications
Released: 1-Nov-2024 9:35 PM EDT
A New Study Highlights Microalgae as Sustainable Ingredients for Food and Pharmaceutical Applications
Chinese Academy of Sciences

A research team has unveiled the unique chemical, microstructural, rheological, and flavor-related properties of four commercially available microalgal species—Arthrospira, Isochrysis, Nannochloropsis, and Tetraselmis.

Released: 31-Oct-2024 2:15 PM EDT
First Pediatric Guideline on Opioid Prescribing in Primary Care Focuses on Preventing Overdose
Ann and Robert H. Lurie Children's Hospital of Chicago

With its emphasis on opioid overdose prevention, the first guideline for primary care providers from the American Academy of Pediatrics (AAP) on prescribing opioids for acute pain in children and adolescents extends beyond responsible pain management.

鶹ý: Rutgers Health Officials Celebrate $47.5 Million Grant to Improve Health Care in New Jersey
Released: 30-Oct-2024 3:40 PM EDT
Rutgers Health Officials Celebrate $47.5 Million Grant to Improve Health Care in New Jersey
Rutgers University-New Brunswick

New Jersey Gov. Phil Murphy joined Rutgers and community leaders on Oct. 30 at the Child Health Institute in New Brunswick to celebrate a $47.5 million federal grant for the Rutgers Institute for Translational Medicine and Science that will improve health and well-being for New Jersey residents over the next seven years.

Released: 30-Oct-2024 11:10 AM EDT
Wake Forest University School of Medicine and Atrium Health Awarded $2.5 Million in PCORI Funding to Improve Antibiotic Prescribing for Childhood Respiratory Infections
Wake Forest University School of Medicine

A team from Wake Forest University School of Medicine and Atrium Health has been approved for a $2.5 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to help improve antibiotic prescribing for children with acute respiratory tract infections in outpatient settings.

Not for public release

This news release is embargoed until 28-Oct-2024 5:00 PM EDT Released to reporters: 22-Oct-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 28-Oct-2024 5:00 PM EDT The 鶹ý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 28-Oct-2024 3:50 PM EDT
Antibody Shows Promise Against Obesity-related Liver Disease and Atherosclerosis in Mice
Federation of American Societies for Experimental Biology (FASEB)

Latest research in the FASEB Journal reveals an antibody called bFKB1 improves liver disease and atherosclerosis in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH), which is associated with obesity.



close
3.33206